Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Jin Hu

4PUBLICATIONS

12CO-AUTHORS

Oncology and carcinogenesis not elsewhere classifiedMolecular targetsAutonomic nervous systemCardiology (incl. cardiovascular diseases)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jul 06, 2025

Clinical Implication of Subcategorizing T2 Category in Metaplastic Breast Cancer.

Zankai Wu, Qingfeng Yang, Yanting Zhang

|May 09, 2025

Targeting PSMD14 combined with arachidonic acid induces synthetic lethality via FADS1 m<sup>6</sup>A modification in triple-negative breast cancer.

Yuanhang Yu, Jin Hu, Wenwen Wang

|Sep 19, 2022

LncRNA SEMA3B-AS1 inhibits breast cancer progression by targeting miR-3940/KLLN axis.

Jin Hu, Haohao Huang, Zihan Xi

|Oct 21, 2020

Combination of serum lactate dehydrogenase and sex is predictive of severe disease in patients with COVID-19.

Jin Hu, Jun Zhou, Fang Dong

Pageof 1

Frequent Collaborators

2 joint publications

Hengyu Chen

2 joint publications

Lei Li

1 joint publications

Tao Huang

1 joint publications

Yuanhang Yu

1 joint publications

Wenwen Wang

1 joint publications

Ende Zhao

1 joint publications

Chong Lu

1 joint publications

Chunping Liu

1 joint publications

Zankai Wu

1 joint publications

Qingfeng Yang

Frequent Collaborators

2 joint publications

Hengyu Chen

2 joint publications

Lei Li

1 joint publications

Tao Huang

1 joint publications

Yuanhang Yu

Top Related Videos

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on : Dec 05, 2017

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on : May 27, 2021

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on : Mar 30, 2019

See more related videos

Top Related Videos

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on : Dec 05, 2017

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on : May 27, 2021

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on : Mar 30, 2019

See more related videos